Xiangxue Pharmaceutical Revenue

In the year 2025, Xiangxue Pharmaceutical had annual revenue of 1.60B CNY, down -14.16%. Xiangxue Pharmaceutical had revenue of 354.16M in the quarter ending March 31, 2026, a decrease of -15.88%.

Revenue

1.60B

Revenue Growth

-14.16%

P/S Ratio

4.16

Revenue / Employee

576.17K

Employees

2,769

Market Cap

6.63B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.60B	-263.25M	-14.16%
Dec 31, 2024	1.86B	-440.63M	-19.16%
Dec 31, 2023	2.30B	112.22M	5.13%
Jan 1, 2023	2.19B	-783.51M	-26.38%
Jan 1, 2022	2.97B	-101.51M	-3.30%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Suzhou Fengbei Biotech Stock	3.61B
Anhui Huaheng Biotechnology	2.95B
Novogene	2.26B
Shenzhen Weiguang Biological Products	1.26B
Chengdu Kanghua Biological Products	1.20B
Wuhan Keqian Biology Co.,Ltd	932.09M
Acrobiosystems	887.21M
Jiangsu Aidea Pharmaceutical Group	699.33M

Revenue Rankings